Skip to content
2000
Volume 23, Issue 10
  • ISSN: 1568-0096
  • E-ISSN: 1873-5576

Abstract

It is possible for tumors to develop resistance to currently used drugs. However, its increasing incidence necessitates further study and the development of novel therapies This review explores our current understanding of the factors that enable drug resistance, which include, inactivation of the drug, reduced drug uptake, increased drug efflux, metabolic effect, inhibition of apoptosis, epithelialmesenchymal transition, modified membrane transport, and heterogeneity of inherent tumor cell. This manuscript will also explore some genetic and epigenetic alterations that may encourage drug resistance and fundamental mechanisms of the reluctance of drugs in leukemia, ovarian and breast cancer and it concludes with a few solutions for managing drug resistance.

Loading

Article metrics loading...

/content/journals/ccdt/10.2174/1568009623666230508110258
2023-11-01
2025-11-01
Loading full text...

Full text loading...

/content/journals/ccdt/10.2174/1568009623666230508110258
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test